AB
OTLK icon

Amalgamated Bank’s Outlook Therapeutics OTLK Stock Holding History

Amalgamated Bank’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-153
Closed – – 3104
2025
Q1 		$0 Hold
153
– – ﹤0.01% 2958
2024
Q4 		$0 Hold
153
– – ﹤0.01% 2979
2024
Q3 		$1K Hold
153
– – ﹤0.01% 2968
2024
Q2 		$1K Hold
153
– – ﹤0.01% 2985
2024
Q1 		$2K Sell
153
-837
-85% -$6.77K ﹤0.01% 2898
2023
Q4 		$8K Sell
990
-45
-4% -$380 ﹤0.01% 2899
2023
Q3 		$5K Hold
1,035
– – ﹤0.01% 2971
2023
Q2 		$36K Buy
1,035
+106
+11% +$2.89K ﹤0.01% 2459
2023
Q1 		$20K Buy
929
+46
+5% +$1.03K ﹤0.01% 2650
2022
Q4 		$19K Hold
883
– – ﹤0.01% 2767
2022
Q3 		$22K Buy
883
+15
+2% +$349 ﹤0.01% 2795
2022
Q2 		$18K Buy
868
+143
+20% +$4.11K ﹤0.01% 2884
2022
Q1 		$26K Sell
725
-61
-8% -$1.91K ﹤0.01% 2721
2021
Q4 		$21K Sell
786
-18
-2% -$642 ﹤0.01% 2143
2021
Q3 		$35K Sell
804
-23
-3% -$1.11K ﹤0.01% 2149
2021
Q2 		$41K Buy
+827
New +$38.4K ﹤0.01% 2175

Other funds holding OTLK

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Amalgamated Bank's OTLK Position: Q2 2025 in Review

Amalgamated Bank sold out of Outlook Therapeutics (OTLK) in Q2 2025, closing a stake of 153 shares.

Amalgamated Bank first reported a position in OTLK in Q2 2021 and held it in 16 quarters. The position peaked at $41K in Q2 2021. 66 funds tracked by Wall St. Rank hold OTLK as of Q2 2025.

  • Amalgamated Bank reported no remaining Outlook Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 153 Outlook Therapeutics shares in Q2 2025.
  • Amalgamated Bank first reported a position in Outlook Therapeutics in Q2 2021 and held it in 16 quarters.
  • Amalgamated Bank's Outlook Therapeutics position peaked at $41K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.